RadNet has acquired ultrasound AI vendor See-Mode Technologies, aiming to enhance workflow efficiency and expand its imaging AI offerings.
Key Details
- 1RadNet completed the acquisition of See-Mode Technologies, an AI company focused on breast and thyroid ultrasound analysis.
- 2See-Mode's FDA-cleared thyroid solution is already deployed at some RadNet outpatient centers, showing a 30% reduction in scan times.
- 3Approximately 20 million ultrasound exams for thyroid and breast are performed annually in the US, highlighting a large addressable market.
- 4RadNet plans to integrate See-Mode’s products into its DeepHealth AI portfolio and market them to third parties.
- 5The deal follows earlier acquisitions of iCAD, Quantib, Aidence, and Kheiron by RadNet, further bolstering their AI division.
- 6Financial terms of the acquisition were not disclosed.
Why It Matters
This acquisition demonstrates RadNet's commitment to expanding AI-driven workflow improvements in high-volume, complex ultrasound exams, potentially increasing access and efficiency. The integration of advanced AI solutions is positioned to benefit both clinicians and patients, with commercial implications for the broader radiology AI market.
Source
Radiology Business
Related News
•Health Imaging
AI-Powered Ultrasound Tool Predicts Delivery Timing for Pregnant Patients
Researchers have created an AI model using ultrasound to accurately forecast expectant mothers’ delivery timelines.
•Radiology Business
Heartflow Raises $364M in Highly Subscribed Public Offering
Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
•Radiology Business
Heartflow Earns UnitedHealthcare Coverage and Targets $1.3B IPO Valuation
Heartflow received nationwide UnitedHealthcare coverage for its AI CT plaque analysis software and announced plans for a $200M IPO at a $1.3B valuation.